IE000B9PQW54.SG - Overview

IE000B9PQW54.SG VanEck Genomics and Healthcare Innovators UCITS ETF | IE000B9PQW54

TER

0.35%

Total Expense Ratio per year

Fund Size

$14100.00B

Assets under management

Holdings

49

Underlying equities

Dividend Yield

N/A

Accumulating

Performance Analysis

Based on selected timeframe (1D)

Top Performers - Upside

Phreesia, Inc. PHR

+4.29%

Veeva Systems Inc. VEEV

+3.71%

Insulet Corporation PODD

+3.08%

Top Performers - Downside

Hims & Hers Health, Inc. HIMS

-14.20%

GeneDx Holdings Corp. WGS

-6.75%

Moderna, Inc. MRNA

-5.17%

Top Contributors - Upside

Veeva Systems Inc. VEEV • Weight: 6.12% • Perf: +3.71%

+0.23% Impact

DexCom, Inc. DXCM • Weight: 6.17% • Perf: +1.50%

+0.09% Impact

Insulet Corporation PODD • Weight: 2.73% • Perf: +3.08%

+0.08% Impact

Top Contributors - Downside

Moderna, Inc. Weight: 5.87% • Perf: -5.17%

-0.30% Impact

Hims & Hers Health, Inc. Weight: 1.88% • Perf: -14.20%

-0.27% Impact

Guardant Health, Inc. Weight: 4.84% • Perf: -1.91%

-0.09% Impact

ETF Profile

Provider VanEck

Region World

Country N/A

Sector Health Care

Strategy Social / Environmental

Theme Innovation

Distribution Policy Accumulating

Replication Full replication

Sustainable Yes

Aggregate Fundamentals

Weighted average of underlying holdings

Avg P/E Ratio 28.38

Avg Forward P/E 51.73

Growth Analysis

EPS Growth (LY->CY) -866.34%

Revenue Growth (LY->CY) +41.39%

EPS Growth (CY->NY) +61.81%

Revenue Growth (CY->NY) +33.87%